Metric Finance
LearnFAQ
LearnFAQ

Learn / ANIP

NASDAQ: ANIP

Ani Pharmaceuticals (ANIP) stock, explained like you're 5

Ani Pharmaceuticals trades on the Nasdaq under the ticker ANIP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.7 billion dollars.

Ticker
ANIP
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.7 billion dollars

Is Ani Pharmaceuticals a small, medium or large cap company?

No. Ani Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.7 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Ani Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ANIP stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • ANIP: ANI Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas (Stocktwits)
  • Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report? (Yahoo Finance)
  • ANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Nikhil Lalwani Sells 5,400 Shares (MarketBeat)
  • Under a trading plan, ANI Pharmaceuticals (ANIP) CEO sells shares at $71.89 on average. (Stock Titan)
  • Is Phase 4 Uveitis Data Altering The Investment Case For ANI Pharmaceuticals (ANIP)? (Simply Wall Street)

Follow ANIP in your daily brief

Each trading day at 5 PM ET we post what happened to Ani Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ANIP

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Ani Pharmaceuticals stock

What does Ani Pharmaceuticals do?

Ani Pharmaceuticals trades on the Nasdaq under the ticker ANIP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.7 billion dollars.

What is the ticker symbol for Ani Pharmaceuticals?

Ani Pharmaceuticals trades under the ticker ANIP on the Nasdaq.

What is Ani Pharmaceuticals's market cap?

Ani Pharmaceuticals is a small cap stock with a market cap of about 1.7 billion dollars.

How does Ani Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ANIP stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ANIP stock every day?

Add ANIP to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ANIP daily

A free brief on Ani Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ANIP: ANIP vs NVS, ANIP vs AZN, ANIP vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed